Last $71.44 USD
Change Today -0.96 / -1.33%
Volume 2.7M
LLY On Other Exchanges
Symbol
Exchange
New York
Mexico
SIX Swiss Ex
Sao Paulo
EN Paris
Frankfurt
As of 3:38 PM 12/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William W. Chin M.D.

Former Senior Vice President of Discovery & Clinical Research, Eli Lilly and Company
AgeTotal Calculated CompensationThis person is connected to 74 board members in 6 different organizations across 7 different industries.

See Board Relationships
----

Background*

Dr. William W. Chin, M.D. serves as an Executive Dean of Research, Bertarelli Professor for Translational Medical Science and Professor of Medicine at Harvard Medical School (HMS). Dr. Chin served as Senior Vice President of Discovery & Clinical Research at Eli Lilly and Company. Dr. Chin served as the Vice President of Discovery Biology Research and Clinical Investigation of Eli Lilly and Company since July 2003. He served as Vice President of gene regulation, bone ...

Read Full Background

Corporate Headquarters*

Lilly Corporate Center
Indianapolis, Indiana 46285

United States

Phone: 317-276-2000
Fax: --

Board Members Memberships*

Director
Director

Education*

BA 1968
Columbia College
MD 1972
Harvard Medical School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LLY:US $71.45 USD -0.95

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vincent A. Forlenza BDChairman, Chief Executive Officer and President
Becton, Dickinson and Company
$930.0K
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$2.7M
Haruo Naito Chief Executive Officer, Representative Corporate Officer and Director
Eisai Co., Ltd.
--
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELI LILLY & CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.